The global Vaccine Contract Manufacturing Market is expanding rapidly, driven by the adoption of advanced production technologies such as viral vector production. With the market expected to reach USD 13.16 billion by 2032, contract manufacturing is becoming a critical component of the vaccine development ecosystem. Viral vector production involves the use of modified viruses to deliver...